
Vesilife Tablet
Marketer
MSN Laboratories
Salt Composition
Solifenacin (10mg)
Overview Vesilife Tablet
Overactive bladder is treated with Vesilife Tablet, a muscarinic receptor blocker. This medication alleviates urinary symptoms such as frequent urination, urgency, and incontinence. Dosage and treatment length should strictly adhere to your physician's instructions. Vesilife Tablet can be ingested with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Common side effects include dry mouth, constipation, nausea, and urinary tract infections. Increased water intake can help manage these. Blurred vision or dizziness are also possible; refrain from driving while using this medication. Before commencing treatment, disclose all other medications and existing health conditions to your doctor. Pregnancy or breastfeeding should also be reported. Patients with liver or kidney impairment require careful monitoring and regular check-ups as directed by their doctor.
Primary Ingredients of Vesilife Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Vesilife Tablet
Managing symptoms associated with overactive bladder
Major Benefits of Vesilife Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vesilife Tablet can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Vesilife Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Nausea
- Upset stomach
- Urinary tract infection
How to use Vesilife Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vesilife Tablet can be consumed with or without food, although consistent timing is recommended.
How Vesilife Tablet works:
Vesilife tablets offer antimuscarinic action, reducing bladder muscle spasms to alleviate urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Vesilife Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Vesilife Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against any possible dangers before prescribing. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Vesilife Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, prolonged Vesilife Tablet use may decrease milk supply and potentially lead to constipation, dry mouth, and urinary tract infection in the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by Vesilife Tablet side effects, such as blurred vision, drowsiness, or fatigue.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vesilife Tablet, potentially requiring dosage modification. Physician consultation is advised. Vesilife Tablet is contraindicated for individuals undergoing renal dialysis.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Vesilife Tablet, potentially requiring dosage modification. Consult a physician before use. Vesilife Tablet is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Vesilife Tablet :
Should you forget a Vesilife Tablet dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vesilife Tablet
| Label | Value |
|---|---|
| Chemical Type | Tetrahydroisoquinoline Quinuclidine Derivative |
| Developing Habits | No. |
| Type of Therapy | Urology |
| Actions | M3 Muscarinic Receptor Antagonist (Bladder-selective) |
